定制开窗Anaconda主动脉袖套治疗复杂腹主动脉瘤的早期结果
该回顾性分析纳入15个中心共29例使用定制开窗Anaconda主动脉袖套治疗复杂腹主动脉瘤的患者,中位年龄74岁,主要技术成功率86%,30天死亡4/29,中位随访11个月估算肾小球滤过率由76降至63 mL/min/m2,1年无再干预生存75%±9%。
要点
- 定制开窗Anaconda袖套可用于既往主动脉修复并发症后或复杂腹主动脉瘤。
- 主要技术成功率86%,次要技术成功率93%,30天死亡4/29。
- 中位随访11个月估算肾小球滤过率由76降至63 mL/min/m2。
核心结论
- 对于既往(腔内)主动脉修复术后复杂病例或复杂腹主动脉瘤,使用该特定定制开窗主动脉袖套治疗是可行的。
- 本研究强调了某些腹主动脉瘤病例的复杂性,在治疗选择有限的选定病例中,开窗Anaconda主动脉袖套是一个有效选择。
研究设计与样本
- 2013年至2016年间,全球38个中心共放置57枚定制开窗Anaconda(Vascutek,Inchinnan,Scotland,UK)主动脉袖套,所有中心受邀参与此项回顾性分析。
- 最终15家诊所参与,共29例。
主要发现
- 手术中位年龄74岁(四分位距71-78岁),5例为女性;2例为开放腹主动脉瘤修复术后吻合口旁腹主动脉瘤,19例为初次腔内腹主动脉瘤修复术后复杂病程,8例为腹主动脉瘤初次手术。
- 共使用76个开窗(平均每例2.6个),4例患者需要7次辅助手术,2例患者中转手术(1例因肠系膜上动脉夹层,1例因肾动脉穿孔)。
- 手术中位时间225分钟(四分位距150-260分钟),中位失血量200 mL(四分位距100-500 mL),中位对比剂用量150 mL(四分位距92-260 mL)。
- 主要技术成功率为86%,次要技术成功率为93%;30天并发症7/29,死亡率为4/29。
- 术前与术后估算肾小球滤过率保持不变(76至77 mL/min/m2);术前至中位随访11个月,估算肾小球滤过率统计学显著下降(76至63 mL/min/m2)。
临床怎么用
- 作者认为,对于既往(腔内)主动脉修复术后复杂病例或复杂腹主动脉瘤,使用该特定定制开窗主动脉袖套治疗是可行的。
- 作者认为,在治疗选择有限的选定病例中,开窗Anaconda主动脉袖套是一个有效选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to investigate the feasibility of a specific custom-made fenestrated aortic cuff in the treatment of complex abdominal aortic aneurysms (AAAs). METHODS: Between 2013 and 2016, a total of 57 custom-made Fenestrated Anaconda (Vascutek, Inchinnan, Scotland, UK) aortic cuffs were placed in 38 centers worldwide. All centers were invited to participate in this retrospective analysis. Postoperative and follow-up data included the presence of adverse events, necessity for reintervention, and renal function. RESULTS: Fifteen clinics participated, leading to 29 cases. Median age at operation was 74 years (interquartile range [IQR], 71-78 years); five patients were female. Two patients were treated for a para-anastomotic AAA after open AAA repair, 19 patients were treated because of a complicated course after primary endovascular AAA repair, and 8 cases were primary procedures for AAA. A total of 76 fenestrations (mean, 2.6 per case) were used. Four patients needed seven adjunctive procedures. Two patients underwent conversion, one because of a dissection of the superior mesenteric artery and one because of perforation of a renal artery. Median operation time was 225 minutes (IQR, 150-260 minutes); median blood loss, 200 mL (IQR, 100-500 mL); and median contrast volume, 150 mL (IQR, 92-260 mL). Primary technical success was achieved in 86% and secondary technical success in 93%. The 30-day morbidity was 7 of 29 with a mortality rate of 4 of 29. Estimated glomerular filtration rate remained unchanged before and after surgery (76 to 77 mL/min/m2). Between preoperative and median follow-up of 11 months, estimated glomerular filtration rate was reduced statistically significantly (76 to 63 mL/min/m2). During follow-up, 9 cases had an increase in aneurysm sac diameter (5 cases >5 mm); 14 cases had a stable or decreased aneurysm sac diameter; and in 2 cases, no aneurysm size was reported. No type I endoleak was reported, and two cases with a type III endoleak were treated by endovascular means during follow-up. Survival, reintervention-free survival, and target vessel patency at 1 year were 81% ± 8%, 75% ± 9%, and 99% ± 1%, respectively. After 2 years, these numbers were 81% ± 8%, 67% ± 11%, and 88% ± 6%, respectively. During follow-up, the two patients with a type III endoleak needed endograft-related reinterventions. CONCLUSIONS: Treatment with this specific custom-made fenestrated aortic cuff is feasible after complicated previous (endovascular) aortic repair or in complex AAAs. The complexity of certain AAA cases is underlined in this study, and the Fenestrated Anaconda aortic cuff is a valid option in selected cases in which few treatment options are left.
引用
- de Niet A, Reijnen MMPJ, Zeebregts CJ, et al. Early results with the custom-made Fenestrated Anaconda aortic cuff in the treatment of complex abdominal aortic aneurysm. J Vasc Surg. 2018. PMID: 30104097. doi:10.1016/j.jvs.2018.05.218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。